In addition, Fäldt Beding et al. (2022) observed high expression of BIRC5 in multiple cancer types in their pan-cancer study and suggested its potential as a prognostic biomarker, particularly showing strong clinical significance in gastric and liver cancers (Fäldt Beding et al., 2022). The gene discussed is BIRC5; the disease is liver cancer.